[
  {
    "ts": null,
    "headline": "HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock",
    "summary": "NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced its intention to voluntarily delist from the Nasdaq Capital Market (“Nasdaq”) and to deregister its common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and susp",
    "url": "https://finnhub.io/api/news?id=429f3866395638ecfb3abad597f257df44b5c3e97b0fc63ffdabdc1a9a3d5035",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752869100,
      "headline": "HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock",
      "id": 136012006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced its intention to voluntarily delist from the Nasdaq Capital Market (“Nasdaq”) and to deregister its common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and susp",
      "url": "https://finnhub.io/api/news?id=429f3866395638ecfb3abad597f257df44b5c3e97b0fc63ffdabdc1a9a3d5035"
    }
  },
  {
    "ts": null,
    "headline": "Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?",
    "summary": "KYMR jumps 70.7% in 3 months as the $750M oncology deal with GILD and pipeline advances in TPD drugs impress investors.",
    "url": "https://finnhub.io/api/news?id=978ba9589840b74dcce816ba4f89643af0f6bd5d251e556383ec68a737bdd842",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752846840,
      "headline": "Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?",
      "id": 136005807,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "KYMR jumps 70.7% in 3 months as the $750M oncology deal with GILD and pipeline advances in TPD drugs impress investors.",
      "url": "https://finnhub.io/api/news?id=978ba9589840b74dcce816ba4f89643af0f6bd5d251e556383ec68a737bdd842"
    }
  }
]